Navigation Links
WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
Date:9/5/2007

- Largest Independent Healthcare Communications Firm Ranked Among Inc.

Magazine's Fastest Growing Companies in the Nation -

NEW YORK and SAN FRANCISCO, Sept. 5 /PRNewswire/ -- WeissComm Partners, the largest independent communications agency focused on the healthcare industry, today announced 10 recent new hires to work on several new and growing accounts in its San Francisco, New York and Chicago offices.

The Company also announced that the 2007 survey of Inc. Magazine's 5000 Fastest Growing Private Companies in the Nation ranked WeissComm 1,033 overall and number 52 among the fastest growing companies based in San Francisco.

The new hires include seasoned corporate communications and investor relations experts Monique Greer, formerly of Dendreon Corporation, and Nicole Foderaro, formerly of Nuvelo, Inc. In addition, several other associates have joined its offices across the country, including Danielle Bertrand, Erin Bittner, Julio Cantre, Jessica Carlson, Julie Normart, Brooke Shenkin, Becky Soja and Adrienne Turner. These new hires bring the number of employees to over 60.

The new clients represent a cross section of WeissComm's diverse portfolio of biotech, medical device, diagnostic and pharmaceutical companies. They include Alsius Corporation, Emphasys Medical, Map Pharmaceuticals, Sagent Pharmaceuticals and Sirion Therapeutics.

"Given the increasing competition to retain talented healthcare communications professionals, it is gratifying to see that our entrepreneurial environment and results-oriented approach that truly impact clients' businesses continue to attract some of the best people in the business," said Diane Weiser, COO of WeissComm. "Our growing roster of high-quality, passionate, seasoned professionals are responsible for the company's continued growth and success."

About WeissComm Partners

WeissComm Partners is a full-service public relations agency focused exclusively on serving the
'/>"/>

SOURCE WeissComm Partners
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Spouses and other partners lower blood pressure says new research
2. Changing Partners may put Expectant Mothers at Risk
3. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
4. Partnership Between Diabetes India And Elsevier Announced
5. Betterment Of Health In Case Of Gay And Lesbian Civil Partnerships
6. Private Public Partnership To Tackle TB, In Karnataka
7. Courting HIV through Marriage or Partnership
8. Jealousy In Men Peaks When Partners Are Most Fertile
9. War Trauma Not Passed On To Partners And Children, Study
10. SRM Inst Signs Mou With Partners Health Care
11. A Healthy Partnership in the Pilbara
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...ug. 29 /PRNewswire-FirstCall/ -- Landauer, Inc. (N...ors declared a regular,quarterly cash dividend of ...008. The dividend will be paid on October 3, 2008,... About Landauer, Landauer is the leading provide... and environmental radiation exposure. For more th...
(Date:8/29/2008)...fic obligation reduced from $250 to $19 million, ...oston Scientific,Corporation (NYSE: BSX ) today a... Texas found two patents of Medtronic, Inc. (NYSE:...ng the prosecution of the patents,before the Unite... previously found that certain Boston Scientific b...
(Date:8/29/2008)... Dr. Milton Owens and the Coastal Center for O...ia to provide protection for cash paying patients ...ic community is benefiting. , .... Milton Owens and the Coastal Center for Obesity ...rovide protection for cash paying patients in the ...
(Date:8/29/2008)... Trusted life science software provider allows...ngage via GSA. , Reston, ...erging software engineering firm dedicated to the...ral Services Administration (GSA) Contract. The GS...h the ability to conveniently engage 5AM Solutions...
Breaking Medicine News(10 mins):Health News:Court Rejects Two Medtronic Patents 2Health News:Court Rejects Two Medtronic Patents 3Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2
...development at Sandia National Laboratories can id...rax in less than five minutes. //Sandia's Laborato...rted the work. Sandia is a multiprogram laboratory...kheed Martin company, for the U.S. Department of E...
...ng great covenant in dental restorative work, say ... and Technology at Ohio.//This ACP has new physica... researcher at OSU. “It’s more soluble than other ...to the stable dental mineral hydroxyapatite, which...
... and Iceland's National University Hospital, ascer...ses a woman's risk by more than 62 per cent.//Endo... tissue, which is normally found only in the linin...he tissue attaches itself to ligaments and organs ...
...e today are more at risk of developing stomach can...earchers at the University of Newcastle believe th... have robbed it off its anti-cancer agents. The r...h indicates that Aspirin may be effective in fight...
Other Medicine News:
(Date:8/27/2008)...in Parts of Bucks, Delaware, Montgomery,Philadelp...e-USNewswire/ -- After encouraging,results followi...tment of,Environmental Protection will continue it...st the mosquito-borne West Nile virus., Targeted ....m. and,midnight in portions of Bucks, Delaware, M...
(Date:8/27/2008)..., melphalan and prednisone arm demonstrated a, si... complete response -, CAMBRIDGE, Mass., Aug. 27 /...pany today announced the publication of results fr... trial in this week,s edition of the,New England J...nt survival,benefit and a 30 percent complete remi...
(Date:8/27/2008)...7 /-, - Oralair(R) Grasses...acodynamic Study Conducted in an Allergen Challeng... positive results of a new study,conducted in an A...alair(R) Grasses included 86 adult patients expose...nt durations: 1 week, 1 month,2 and 4 months with...
(Date:8/27/2008)...rom BLISS-52 trial, expected by mid-2009 - - Data...fall 2009 -, ROCKVILLE, Md., Aug. 27 /PRNewswire-... HGSI ) today announced it has completed enrollme...wo pivotal Phase 3,randomized clinical trials of L... systemic lupus erythematosus (SLE). Belimumab is ...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Hiemstra Approved to Manufacture Medical Devices in New CER 9345 1Hiemstra Approved to Manufacture Medical Devices in New CER 9345 2TeamStaff Receives Nasdaq Determination Letter 9340 1TeamStaff Receives Nasdaq Determination Letter 9340 2TeamStaff Receives Nasdaq Determination Letter 9340 3Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 1Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 2Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 3Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 4Chromosome Abnormalities Raise Risk for Autism 9333 1Chromosome Abnormalities Raise Risk for Autism 9333 2Chromosome Abnormalities Raise Risk for Autism 9333 3Chromosome Abnormalities Raise Risk for Autism 9333 4
...Family History of ESRD Are at High,Risk , ,WASHIN...f U.S.,adults have a family history of end-stage r...to be at increased risk of developing,kidney disea...l of,the American Society of Nephrology. , "A fami...frican-Americans, who are also at substantially hi...
...ibody significantly reduced the number of,new or e...bmitted,for presentation at upcoming medical meeti...12, 2007,/PRNewswire-FirstCall/ -- Biogen Idec, In...hat the ongoing CHOICE trial, a Phase 2,randomize...zumab,met its primary endpoint in relapsing multi...
Other Medicine Technology:Nearly 1 in 10 Americans Has A Relative With Kidney Failure 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 3Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 4Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 5
...nterior Spinal Implant system. Material that has a...cal bone. The result is an implant that meets the ..., while optimizing the fusion environment through ...omic design with 5 and 10 degrees of lordosis. Min...
...Cage System provides anterior column support for s...ctomies from T1 to L5. The system consists of one ...tacked to a desired height, accommodating various ...lymer material emulates the biomechanical properti...
The primary goals in interbody fusion are to immobilize the affected vertebrae, to restore disc space height and sagittal alignment, and to provide an enviroment for bone fusion between vertebral bod
Flexoscope images are transmitted through sorted fiberglass bundles that record the picture and transmit it to a user's eye. Karl Storz flexoscopes are designed for rough, industrial handling and can
Medicine Products: